ACTO
PrivateLast Round
Corporate Funding
Sep 12, 2024
Total Funding Raised
$41.3M
Company Overview
ACTO operates in Enterprise Software and is based in Toronto. Its latest recorded funding round was a Corporate Funding round in September 2024.
ACTO is a life sciences technology company that provides an AI-powered Intelligent Field Excellence platform to enhance the performance of field representatives through training, coaching, and content management.
Sector
Enterprise Software
Verticals
Sales Enablement, NLP & Conversational AI, Workflow Automation, Compliance, Customer Experience
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ACTO Comparables
Compare ACTO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SmartWinnr | 83% | |
| Quantified | 79% | |
| Allego | 78% |
For institutional investors. Book with your work email.
ACTO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Sep 12, 2024 | ||||
| Series B | Jul 7, 2022 | ||||
| Series A | Aug 27, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ACTO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Graphite Ventures | Corporate Funding |
| Maple Leaf Angels | Seed |
| Panache Ventures | Corporate Funding, Series A, Seed, Series B |
| MaRS Discovery District | Series A, Series B |
| Questa Capital | Corporate Funding, Series B |
| Salesforce Ventures | Series A, Series B |
| Innovation Grade Ventures | Corporate Funding, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 13, 2026
Launched SuperAgents, an AI innovation for Life Sciences professionals.
- Mar 18, 2026
Launched AI agents for accelerated Field Excellence in Life Sciences.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 5, 2026
Everest Group recognizes ACTO Technologies Inc. as a Luminary in its Innovation Watch: Agentic AI in Life Sciences Commercial 2026, placing it among 22 evaluated providers with the strongest market performance and ecosystem drivers on Oct 5th '26 in Ontario and New York.
- recognized_asOct 5, 2026
Everest Group positions ACTO Technologies Inc. as a Luminary in its Innovation Watch: Agentic AI in Life Sciences Commercial 2026, recognizing the company alongside strategic partners Veeva and Salesforce.
- recognized_asSep 14, 2026
Everest Group recognized ACTO Technologies Inc. among its Top 50(TM) Pharmaceutical Technology Providers for 2026 in Canada and the United States on Sep 14th '26
- recognized_asSep 2, 2026
ACTO Technologies Inc. achieved Veeva Gold Product Partner status from Veeva on Sep 2nd '26 in Canada and New York, joining a select group of Veeva Gold Product Partners after nearly a decade of collaboration focused on shared customer success.
- partners_withSep 2, 2026
On Dec 1st '21, ACTO Technologies Inc. and Veeva Systems advance their partnership through a newly certified integration that uses CRM data on sales representatives’ territories and product focus areas to deliver more relevant training content to field teams.
For institutional investors. Book with your work email.
ACTO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ACTO's valuation, stock price, and market status.
Is ACTO a public or private company?
ACTO is a private company.
What is the current stock price of ACTO?
ACTO is a private company, so its shares have no public market price. Caplight tracks ACTO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ACTO worth (valuation)?
Valuation information for ACTO is not publicly available.
Can I buy ACTO stock?
ACTO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ACTO's last funding round?
ACTO's most recent funding round was Corporate Funding on September 12, 2024.
Who are the main investors in ACTO?
Key investors in ACTO include Questa Capital, Resolve Growth Partners.
Will ACTO IPO soon?
No public IPO plans have been announced for ACTO.
How can I track ACTO secondary market activity?
Caplight tracks bids, offers, and trades in ACTO's shares on secondary markets.